AI-powered cardiac monitoring in just 30 seconds a day.

By combining ECG and PCG in a single non-invasive device, Sensocor ML enables earlier detection and continuous understanding of cardiac conditions. 
Developed with clinicians since 2020 and currently in clinical trials, Sensocor ML is progressing toward CE marking, expected before June 2026.

Alongside our device, we develop AI-driven software solutions for hospitals, designed to optimize clinical workflows, improve decision-making, and support scalable patient monitoring.

Monitoring Life

Org chart

Teams

Offices